NantHealth, Oncotest-Teva Signs Reseller Deal

News   Dec 07, 2016

 
NantHealth, Oncotest-Teva Signs Reseller Deal
 
 
 

RELATED ARTICLES

Breakthrough Leads to New Research Into Cancer Treatment for Children

News

The new form of treatment is based on the protein molecule named CD40, which destroys cancerous tumours without harming healthy cell tissue.

READ MORE

Generating T Cells With a More Powerful Anti-cancer Effect

News

Studies of two T cell types that are equally activated by alpha-fetoprotein, a well-established antigen made by liver cancer, show that while one starts off with a bang, the other endures as the more powerful tumor fighter.

READ MORE

Gene Therapy Improves Heart Function by up to 25%

News

Intracoronary delivery of the gene vector was safe and improved heart function in a large animal model.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Diagnostics Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE